Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma

被引：2
|
作者：
Kumar, Vinay [1 ]
Shukla, Surendra Kumar [2 ]
机构：
[1] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Wexner Med Ctr, Columbus, OH 43210 USA
[2] OU Hlth Stephenson Canc Ctr, Dept Oncol Sci, Oklahoma City, OK 73104 USA
来源：
FRONTIERS IN MOLECULAR BIOSCIENCES | 2023年 / 10卷
关键词：
hepatocellular carcinoma (HCC); immunotherapy; metabolic alterations; gene network; HCC prognosis; liver cancer; CANCER;
D O I：
10.3389/fmolb.2023.1202614
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
    Giraldo, Nicolas A.
    Drill, Esther
    Satravada, Baby A.
    El Dika, Imane
    Brannon, A. Rose
    Dermawan, Josephine
    Mohanty, Abhinita
    Ozcan, Kerem
    Chakravarty, Debyani
    Benayed, Ryma
    Vakiani, Efsevia
    Abou-Alfa, Ghassan K.
    Kundra, Ritika
    Schultz, Nikolaus
    Li, Bob T.
    Berger, Michael F.
    Harding, James J.
    Ladanyi, Marc
    O'Reilly, Eileen M.
    Jarnagin, William
    Vanderbilt, Chad
    Basturk, Olca
    Arcila, Maria E.
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5359 - 5367
  • [22] Editorial on immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
    Ruff, Samantha M.
    Pawlik, Timothy M.
    IMMUNOTHERAPY, 2023, 15 (16) : 1323 - 1326
  • [23] Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma
    Yang, Shuai
    Zheng, Lu
    Li, Lingling
    Zhang, Jiangang
    Wang, Jingchun
    Zhao, Huakan
    Chen, Yu
    Liu, Xudong
    Gan, Hui
    Chen, Junying
    Yan, Mei
    He, Chuanyin
    Li, Kai
    Ding, Chen
    Li, Yongsheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (06):
  • [24] Molecular characterization of long-term survivors of hepatocellular carcinoma
    Shen, Junwei
    Hu, Jing
    Wu, Jiawen
    Luo, Xiaoli
    Li, Yanfei
    Li, Jue
    AGING-US, 2021, 13 (05): : 7517 - 7537
  • [25] Targets of immunotherapy for hepatocellular carcinoma: An update
    Rai, Vikrant
    Mukherjee, Sandeep
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (01) : 140 - 157
  • [26] IDENTIFICATION OF TARGETS FOR TCR-IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA USING A CLINICALLY RELEVANT PLATFORM
    Maravelia, P.
    Potti, A. Perez
    Silva, D. Nascimento
    Healy, K.
    Sekine, T.
    Chrobok, M.
    Jorns, C.
    Sallberg, M.
    Buggert, M.
    Pasetto, A.
    CYTOTHERAPY, 2021, 23 (05) : S90 - S90
  • [27] Identification of the Top 10 Core Genes as Diagnostic and Therapeutic Targets in Hepatocellular Carcinoma (HCC)
    Wu, Qiangsheng
    Yin, Yumei
    Gao, Hui
    Chen, Baoding
    Yu, Jianjun
    Zhang, Jian
    Zhu, Donglai
    Liu, Fang
    Ge, Guohong
    Dang, Ya-Mei
    PAKISTAN JOURNAL OF ZOOLOGY, 2023, 55 (06) : 2849 - 2858
  • [28] Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis
    Hossen, Md. Alim
    Reza, Md. Selim
    Harun-Or-Roshid, Md.
    Islam, Md. Ariful
    Siddika, Mst. Ayesha
    Mollah, Md. Nurul Haque
    CURRENT CANCER DRUG TARGETS, 2023, 23 (07) : 547 - 563
  • [29] Hepatocellular carcinoma: Therapeutic advances in signaling,epigenetic and immune targets
    Daniel Neureiter
    Sebastian Stintzing
    Tobias Kiesslich
    Matthias Ocker
    World Journal of Gastroenterology, 2019, 25 (25) : 3136 - 3150
  • [30] Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
    Cao, Lu-Qi
    Xie, Yuhao
    Fleishman, Joshua S.
    Liu, Xuan
    Chen, Zhe-Sheng
    CANCER LETTERS, 2024, 597
12345